Skip to content

Cannabis produces acute hyperphagia in humans and rodents via increased reward valuation for, and motivation to, acquire food.

Catherine Hume, Carrie Cuttler, Samantha L Baglot, Lucia Javorcikova, Ryan J Mclaughlin, Matthew N Hill

Proceedings of the National Academy of Sciences December 30, 2025 DOI: 10.1073/pnas.2518863122 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Translational study Peer reviewed
Population Human participants and rats
Intervention cannabis vapor inhalation
Topics Cannabis
Keywords Appetite Macronutrients Motivation Vapor inhalation
Key points Vaporized cannabis acutely and robustly increases energy intake in humans and rats by reducing latency to eat and increasing feeding bouts, mediated by central CB1 receptors.

Abstract

With approximately 4% of the world's population using cannabis, there is a need to better understand its physiological effects. Cannabis consumption acutely promotes food intake ("the munchies") via delta-9-tetrahydrocannabinol-mediated activation of cannabinoid 1 receptors (CB1R); however, these appetitive effects have not been well characterized. We examined effects of cannabis vapor inhalation on energy and macronutrient intake patterns in human participants and then validated these findings in a translational rat model through which we explored behavioral and physiological mechanisms subserving this response. Vaporized cannabis acutely and robustly increased energy intake. In humans, this occurred in the first 30 min of snack and beverage access, irrespective of dose or gender. In rats, these effects were observed in the first 60 min of food access, irrespective of macronutrient content, satiation, or sex, and were a result of cannabis vapor reducing latency to eat and increasing feeding bout number. Also, cannabis vapor did not change the proportion of macronutrients consumed by human participants and abolished preexisting macronutrient-specific food preferences in rats. Our rat data indicate that cannabis vapor may override homeostatic appetite regulation by increasing motivation to eat and reducing food reward devaluation to promote energy intake. Finally, cannabis vapor did not alter circulating appetite-associated hormones, and these feeding effects were mediated by central, but not peripheral, CB1Rs. This study complements and builds upon previous literature to characterize the appetitive effects of vaporized cannabis and uses a translational approach to examine cannabis-driven energy and macronutrient intake patterns in humans and rodents.

Comparable studies

Other preclinical and animal studies on cannabis, most cited first.

Study Year Design Participants
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors Mice 2015 Preclinical study
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). hMDR1- and hBCRP-transfected HEK293 cells and hMDR1- and hBCRP-MDCKII cells 2010 In vitro study
Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure Mice prenatally exposed to THC, including conditional CB1R knockout mice 2020 Animal experimental study
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway Mice exposed to chronic THC early in life 2018 Animal experimental study
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain Spontaneously hypertensive rats (SHRs) and Wistar rats 2014 Animal experimental study

Citations in the library

Explore topics